PSC Biotech Partners with Clever Culture Systems to Bring AI-Enabled Microbiology Automation to Pharma Manufacturers

Founded in 1996, PSC Biotech Corporation now serves more than 1,000 clients worldwide through professional services consulting, life science equipment rentals and sales, cloud-based software solutions, and pharmaceuticals contract manufacturing.

Clever Culture Systems (ASX: CC5), based in Adelaide, South Australia, provides intelligent automation for microbiology labs. Its APAS® Independence uses AI and machine learning to automate the imaging, analysis, and interpretation of microbiology culture plates.

POMONA, CA, UNITED STATES, November 10, 2026 /EINPresswire.com/ -- PSC Biotech is pleased to announce its appointment as the sole Sales Agent for Clever Culture Systems’ APAS® Independence across the pharmaceutical manufacturing market in the United States, Canada, and Singapore.

APAS® Independence uses artificial intelligence and machine learning to automate the imaging, analysis, and interpretation of microbiology culture plates. The technology remains the only US FDA-cleared artificial intelligence technology for automated culture plate reading. In pharmaceutical manufacturing environments, it reads environmental monitoring plates, helping microbiology laboratories reduce manual plate reading and improve consistency.

This partnership brings together PSC Biotech’s 30 years of experience in pharmaceutical consulting, validation, and compliance with Clever Culture Systems’ AI-driven microbiology automation. PSC Biotech will introduce APAS® Independence to its established network of pharmaceutical manufacturers, providing customers with access to an established technology along with the local expertise to qualify and validate it within regulated GMP environments.

PSC Biotech now represents APAS® Independence alongside the other advanced technologies it brings to the life sciences industry, including De Lama’s sterilization and decontamination systems, Climet Instrument's next generation particle counters and microbial air samplers, and Blue Ocean Robotics’ UVD Robot Pharma autonomous UV-C disinfection solution for cleanrooms. Together, these solutions support a modern contamination control strategy, from sterilization and cleanroom disinfection to environmental monitoring.

As part of the partnership, PSC Biotech will install an APAS® Independence instrument in BioTechnique, its sterile fill-finish contract manufacturing facility in York, Pennsylvania. The system will be qualified and validated onsite for GMP use, establishing a US Center of Excellence where customers can see the technology at work in a live pharmaceutical manufacturing environment through demonstrations and evaluations.

“PSC Biotech is committed to bringing innovative technologies to our customers that support compliance, efficiency, and product quality. APAS® Independence is a natural fit alongside the sterilization and disinfection solutions we already offer. Combined with our validation capabilities and our Center of Excellence at BioTechnique, we can help customers adopt AI-enabled microbiology with confidence, from evaluation through to GMP use.” – Alfonso Fasano, Head of New Technologies, Partnerships & Innovation, PSC Biotech Corporation

“Our relationships across the pharmaceutical industry give us a strong platform to introduce APAS® Independence to a much broader customer base. By combining Clever Culture Systems’ innovative technology with our pharmaceutical expertise and reach, we can help our customers improve the efficiency and quality of their microbiological testing.” – John Clapham, CEO, PSC Biotech Corporation

“We have successfully established APAS® Independence with leading global pharmaceutical manufacturers. The PSC Biotech partnership provides a new, complementary channel to broaden our reach across the US pharmaceutical market, particularly into mid-tier and regional manufacturers.” – Brent Barnes, CEO and Managing Director, Clever Culture Systems

About PSC Biotech
Founded in 1996, PSC Biotech Corporation was created with the vision of providing life science companies unmatched support. To date, PSC Biotech Corporation now serves more than 1,000 clients worldwide through professional services consulting, life science equipment rentals and sales, cloud-based software solutions, and pharmaceutical contract manufacturing.

PSC Biotech Corporation has three unique active divisions within the parent company, each representing one of our areas of expertise: PSC Biotech, PSC Software, and BioTechnique. Together, these divisions enable us to meet the ever-changing needs of our clients with a commitment to excellence and superior quality.

To learn more, visit www.biotech.com, www.pscsoftware.com, and www.biotechnique.com
PSC Biotech Corporation
Phone: +1 909 784 3350
Email: info@biotech.com

About Clever Culture Systems
Clever Culture Systems (ASX: CC5) provides intelligent automation solutions to microbiology laboratories. Based in Adelaide, South Australia, the company developed the Automated Plate Assessment System (APAS® Independence), which uses artificial intelligence and machine learning to automate the imaging, analysis, and interpretation of microbiology culture plates.

To learn more, visit www.cleverculturesystems.com.
Clever Culture Systems
Phone: +61 8 8227 1555
Email: info@cleverculturesystems.com

PSC Biotech
PSC Biotech Corporation

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.